CarboplatinDeoxycytidineAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelCisplatinLung NeoplasmsDrug Administration ScheduleAntimetabolites, AntineoplasticTreatment OutcomeCarcinoma, Non-Small-Cell LungVinblastineDisease-Free SurvivalSurvival AnalysisTaxoidsInfusions, IntravenousSurvival RateNeoplasm StagingPancreatic NeoplasmsAntineoplastic AgentsOrganoplatinum CompoundsCyclophosphamideCombined Modality TherapyEtoposideDoxorubicinOvarian NeoplasmsBiliary Tract NeoplasmsChemotherapy, AdjuvantVincristineNeutropeniaFluorouracilThrombocytopeniaDose-Response Relationship, DrugIfosfamideAdenocarcinomaNeoplasm MetastasisBleomycinSalvage TherapyMaximum Tolerated DoseLeukopeniaGuanineDisease ProgressionArea Under CurvePrognosisNeoplasm Recurrence, LocalGlutamatesQuality of LifeMethotrexateNeoadjuvant TherapyProcarbazinePlatinumEpothilonesTesticular NeoplasmsCamptothecinMuscle NeoplasmsDrug Resistance, NeoplasmCarcinoma, Transitional CellCarcinoma, Small CellPrednisoneAntineoplastic Agents, PhytogenicUrinary Bladder NeoplasmsMechlorethamineTegafurNauseaNeoplasms, Germ Cell and EmbryonalBreast NeoplasmsKaplan-Meier EstimateOxonic AcidCystectomyHematologic DiseasesNeoplasmsDrug EvaluationCytarabineHodgkin DiseaseClinical Trials as TopicDrug Therapy, CombinationActuarial AnalysisFollow-Up StudiesLymphoma, Non-HodgkinCarcinomaAltretamineDeoxycytidine KinaseRemission InductionDrug SynergismPeritoneal NeoplasmsGerminomaLeiomyosarcomaCarmustineLomustineVomitingTime FactorsUrologic NeoplasmsAntineoplastic Agents, AlkylatingEpirubicinCell Line, TumorNeoplasms, Unknown PrimaryMelphalanMitomycinAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedThiotepa